Epidemiology of invasive Candida infection in a neonatal intensive care unit in France

Acta Paediatrica, International Journal of Paediatrics

Volumn 101, Issue 3, 2012, Pages

  Nguyen, Kim An ^a   Zmeter, Georges ^a   Claris, Olivier ^a   Kassai, Behrouz ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BLOOD CULTURE; CANDIDA ALBICANS; CANDIDIASIS; CEREBROSPINAL FLUID; DISEASE SURVEILLANCE; DOSE RESPONSE; FRANCE; FUNGAL COLONIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; TREATMENT DURATION; URINE CULTURE; VERY LOW BIRTH WEIGHT;

CANDIDIASIS, INVASIVE; CROSS INFECTION; FRANCE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES;

EID: 84856329008     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2011.02514.x     Document Type: Article

References (14)

1. Benjamin DK Jr, Stoll BJ, Gantz MG, Walsh MC, Sanchez PJ, Das A, et al., Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics 2010; 126: e865-73.
2. Kaufman DA,. Challenging issues in neonatal candidiasis. Curr Med Res Opin 2010; 26: 1769-78.
3. Stoll BJ, Gordon T, Korones SB, Shankaran S, Tyson JE, Bauer CR, et al., Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129: 63-71. (Pubitemid 26277248)
4. Benjamin DK Jr, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al., Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006; 117: 84-92. (Pubitemid 46050523)
5. Clerihew L, Austin N, McGuire W,. Systemic antifungal prophylaxis for very low birthweight infants: a systematic review. Arch Dis Child Fetal Neonatal Ed 2008; 93: F198-200. (Pubitemid 352039286)
6. Reed BN, Caudle KE, Rogers PD,. Fluconazole prophylaxis in high-risk neonates. Ann Pharmacother 2010; 44: 178-84.
7. Howell A, Isaacs D, Halliday R,. Oral nystatin prophylaxis and neonatal fungal infections. Arch Dis Child Fetal Neonatal Ed 2009; 94: F429-33.
8. Cotten CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin DK Jr,. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006; 118: 717-22. (Pubitemid 46085430)
9. Benjamin DK Jr, Garges H, Steinbach WJ,. Candida bloodstream infection in neonates. Semin Perinatol 2003; 27: 375-83. (Pubitemid 37363190)
10. Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G, et al., A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 2007; 356: 2483-95. (Pubitemid 46919774)
11. Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB,. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001; 107: 293-8. (Pubitemid 32121244)
12. Kaufman D,. Fungal infection in the very low birthweight infant. Curr Opin Infect Dis 2004; 17: 253-9. (Pubitemid 38703856)
13. Manzoni P, Farina D, Leonessa M, d'Oulx EA, Galletto P, Mostert M, et al., Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 2006; 118: 2359-64. (Pubitemid 46397574)
14. Baley JE, Kliegman RM, Boxerbaum B, Fanaroff AA,. Fungal colonization in the very low birth weight infant. Pediatrics 1986; 78: 225-32. (Pubitemid 16039549)